Addolorato, G., Caputo, F., Capristo, E., et al (2001) Diazepam in the treatment of GHB dependence (letter). British Journal of Psychiatry, 178, 183.
Antoniou, T. & Tseng, A. L. (2002) Interactions between recreational drugs and antiretroviral agents. Annals of Pharmacotherapy, 36, 1598–1613.
Barbaccia, M. L., Colombo, G., Affricano, D., et al (2002) GABAB receptor moderated increase in neurosteroids by gamma-hydroxybutyric acid. Neuropharmacology, 42, 782–791.
Carai, M. A. M., Colombo, G., Brunetti, G., et al (2001) Role of GABAB receptors in the sedative/hypnotic effect of gamma-hydroxybutyric acid. European Journal of Pharmacology, 428, 315–321.
Chin, M., Kreutzer, R. & Dyer, J. (1992) Acute poisoning from gamma-hydroxybutyrate overdose. Annals of Emergency Medicine, 31, 716–722.
Colfax, G. N., Mansergh, G., Guzman, R., et al (2001) Drug use and sexual risk behaviour among gay and bisexual men who attend circuit parties: a venue-based comparison. Journal of Acquired Immune Deficiency Syndromes, 28, 373–379.
Degenhardt, L., Darke, S. & Dillon, P. (2002) GHB use amongst Australians: characteristics, use patterns and associated harm. Drug and Alcohol Dependence, 67, 89–94.
Degenhardt, L., Darke, S. & Dillon, P. (2003) The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. Addiction, 98, 199–204.
Deveaux, M., Renet, S., Renet, V., et al (2002) Is gamma-hydroxybutyric acid (GHB) really used in rave-parties and as a date rape drug in France?
Acta Clinica Belgica, 57, 37–40.
Dyer, J. (1991) Gamma-hydroxybutyrate: a health food product producing coma and seizure like activity. American Journal of Emergency Medicine, 9, 321–324.
Espinosa, G., Miro, O., Nogue, S., et al (2001) Liquid ecstasy poisoning: study of 22 cases. Medicina Clinica, 117, 56–58.
Gallimberti, L., Canton, G., Gentile, N., et al (1989) Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet, ii, 787–789.
Galloway, G., Frederick, S., Staggers, F., et al (1997) Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependency. Addiction, 92, 89–96.
Gobaille, S., Schleef, C., Hechler, V., et al (2002) Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Sciences, 70, 2101–2112.
Gross, S. R., Barrett, S. P., Shestowsky, J. S., et al (2002) Ecstasy and drug consumption patterns: a Canadian rave population study. Canadian Journal of Psychiatry, 47, 546–551.
Hechler, V., Ratomponirina, C. & Maitre, M. (1997) Gamma-hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide. Journal of Pharmacology and Experimental Therapeutics, 281, 753–760.
Iten, P. X. & Oestreich, A. (2002) Gamma-hydroxybutyrate (GHB): a new generation of drugs from the chemical shelf. Chimia, 56, 91–95.
Itzhak, Y. & Ali, S. F. (2002) Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Annals of the New York Academy of Sciences, 965, 451–460.
Kam, P. & Yoong, F. (1998) Gamma-hydroxybutyric acid: an emerging recreational drug. Anaesthesia, 53, 1195–1198.
Karch, S. B., Stephens, B. G. & Nazareno, G. V. (2001) GHB – Club drug or confusing artefact?
American Journal of Forensic Medicine and Pathology, 22, 266–269.
Laborit, H. (1964) Sodium 4-hydroxybutyrate. International Journal of Neuropharmacology, 3, 433–452.
Mahr, G., Bishop, C. L. & Orringer, D. J. (2001) Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) use. Psychosomatics, 45, 439–440.
Mamelak, M. (1989) Gamma-hydroxybutyrate: an endogenous regulator of energy metabolism. Neuroscience and Biobehavioral Review, 13, 187–198.
Marinetti, L. J., Isenschmid, D. S., Hepler, B. R., et al (2001) Response to the presence of gamma-hydroxybutyric acid (GHB) in postmortem biological fluids. Journal of Analytical Toxicology, 25, 356–357.
Mattison, A. M., Ross, M. W., Wolfson, T., et al (2001) Circuit party attendance, club drug use and unsafe sex in gay men. Journal of Substance Abuse, 13, 119–126.
Miotto, K. & Roth, B. (2001) GHB Withdrawal Syndrome. Austin, TX: Texas Commission on Drug and Alcohol Abuse.
Miotto, K., Darakjian, J., Basch, J., et al (2001) Gamma-hydroxybutyric acid: patterns of use, effects and withdrawal. American Journal on Addictions, 10, 232–241.
Miro, O., Nogue, S., Espinosa, G., et al (2002) Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. Journal of Toxicology – Clinical Toxicology, 40, 129–135.
Nicholson, K. L. & Balster, R. L. (2001) GHB: a new and novel drug of abuse. Drug and Alcohol Dependence, 63, 1–22.
Palatini, P., Tedeschi, L., Frison, G., et al (1993) Dose-dependent absorption and elimination of Gamma-hydroxybutyric acid in healthy volunteers. European Journal of Clinical Pharmacology, 45, 353–356.
Price, G. (2000) In-patient detoxification after GHB dependence. British Journal of Psychiatry
, 177, 181.
Rosenberg, M. H., Deerfield, L. J. & Baruch, E. M. (2003) Two cases of severe gamma-hydroxybutyrate withdrawal delerium on a psychiatric unit: recommendations for management. American Journal of Drug and Alcohol Abuse, 29, 487–496.
Schneir, A. B., Ly, H. T. & Clark, R. F. (2001) A case of withdrawal from the GHB precursors gamma butyrolactone and 1,4-butanediol. Journal of Emergency Medicine, 21, 31–33.
Scrima, L., Hartman, P. G., Johnson, F. H., et al (1990) The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients – a double blind study. Sleep, 13, 470–490.
Sivilotti, M. L. A., Burns, M. J., Aaron, C. K., et al (2001) Pentobarbital for severe gamma-butyrolactone withdrawal. Annals of Emergency Medicine, 38, 660–665.
Snead, O. C. & Nichols, A. C. (1987) Gamma-hydroxybutyric acid binding sites: evidence for coupling to a chloride anion channel. Neuropharmacology, 26, 1519–1523.
Tarricone, L. (2000) GHB treatment of alcohol and drug addiction. European Psychiatry, 15, 420.
Teter, C. J. & Guthrie, S. K. (2001) A comprehensive review of MDMA and GHB: Two common club drugs. Pharmacotherapy, 21, 1486–1513.
Tong, T. & Boyer, E. W. (2002) Club drugs, smart drugs, raves and circuit parties: An overview of the club scene. Pediatric Emergency Care, 18, 216–218.
Whitten, L. (2001) Conference highlights increasing GHB abuse. NIDA Notes, 16, 10–11.
Winstock, A. R., Griffiths, P. & Stewart, D. (2001) Drugs and the dance music scene: a survey of current drug use patterns amongst a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence, 64, 9–17.